|Articles|July 29, 2020

Early COVID-19 Cases Linked to China, Italy, Iran

People with travel links to China, Iran, and Italy may have accounted for nearly two-thirds of early COVID-19 cases in affected countries.

A new study published in The Lancet Infectious Diseases suggests that people with travel links to China, Iran, and Italy accounted for nearly two-thirds of initial COVID-19 cases in affected countries.

Data on the early spread of SARS-CoV-2 are limited and the global epidemiology of confirmed cases outside of mainland China will likely be a point of scientific inquiry for some time due to complex transmission dynamics.

Investigators publishing in The Lancet sought to move this area of epidemiological research forward by compiling information in publicly available reports from the pre-pandemic period leading up to March 10, 2020.

Reports were gathered via public health agency websites, transcripts of press conferences, and social media feeds of government agencies.

Travel history, exposures to other cases, and case characteristics were noted.

In each of 99 affected countries outside of mainland China, 75 (76%) had recent travel to affected countries. According to investigators, 60 (61%) had travelled to China, Italy, or Iran.

Among 1200 cases examined with age or sex information available, 874 (73%) were early cases. Early cases were defined as within the first 100 a country records.

Among 762 early cases with age information, the median age was 51 years (IQR 35—63); 25 (3%) of 762 early cases occurred in children younger than 18 years.

Additionally, 21 (2%) of these 1200 cases were among health care workers.

Out of 101 clusters identified during the pre-pandemic period, the most commonly identified transmission setting was households (76 [75%]; mean 2·6 cases per cluster [range 2—7]).

The second and third most common sources of an outbreak appeared to be in non-health-care occupational settings (14 [14%]; mean 4·3 cases per cluster [2—14]), and large scale community gatherings (11 [11%]; mean 14·2 cases per cluster [4–36]).

The investigators point out that although close household contact was an overwhelmingly large source of early clusters, clusters in occupational or community settings tended to be large. This means the results should not be taken as an endorsement or rejection of particular outbreak control policies by the authors.


Related to this article

Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Measles Update: October 16, 2026
The latest CDC numbers show an 8.1% increase in measles cases from week-to-week, bringing the 2026 US total to 4410 confirmed cases. A CDC disease detective is going to Pennsylvania to aid in the state's massive outbreak, and the agency reports on a rare measles complication that is uniformly fatal.